Evidence map›Paper›PMID 41546122›Full record

ArticleJournal of cheminformatics2026

Ai derivation and exploration of antibiotic class spaces.

Adam Bess, Sean Rowland, Chris Alvin, Supratik Mukhopadhyay

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Frontiers in bioinformatics · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adam Bess *Department of Computer Science, Louisiana State University, Baton Rouge, LA, 70803, USA.
Sean Rowland *Department of Computer Science, Furman University, Greenville, SC, 29613, USA.
Chris Alvin *Department of Computer Science, Furman University, Greenville, SC, 29613, USA. calvin@deepdrug.ai.
Supratik MukhopadhyayDepartment of Environmental Sciences, Louisiana State University, Baton Rouge, LA, 70803, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe rapid evolution of antibiotic-resistant bacteria poses an urgent global health crisis. A key gap in current antibiotic discovery approaches is the absence of automated chemical synthesis methods designed to systematically generate and evaluate compounds within specific antibiotic classes. We address this gap through fragment-based computational experiments that systematically explore antibiotic chemical spaces.

methodsOur computational methodology consists of three steps: fragmentation of known compounds (eMolFrag), generating new molecular structures by recombining fragments (eSynth), and filtering of candidates based on desired properties (eFilter). eFilter combines structural analysis, pathway information, and protein targets to predict pharmacokinetic properties and therapeutic efficacy. We conducted three experiments: historical reconstruction of penicillin derivatives, hybrid molecule design combining functional groups from multiple antibiotic classes, and chemical space exploration of recently discovered antibiotics.

resultsStarting from Penicillin G and Methicillin, eSynth generated over 1.4 million potential penicillin derivatives. eFilter computationally predicted ampicillin, amoxicillin, and 10 other penicillin derivatives as high-scoring candidates, demonstrating that the pipeline can navigate the chemical space of

conclusionsOur fragment-based pipeline demonstrates the feasibility of systematically exploring antibiotic chemical spaces through computational reconstruction of historical development pathways and generation of hybrid molecules with with predicted multi-target binding profiles. All results represent computational predictions requiring experimental validation.

Indexed as

Antibiotic discoveryAntibiotic resistanceChemical spaceFragment-based drug designHistorical reconstructionHybrid antibioticsIn silico analysisMachine learningPharmacokineticsProtein targets

Identifiers

PMID41546122
PMCPMC12896280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.